ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/29 | 3,185 | 3,195 | 3,140 | 3,195 | -40 | -1.2% | 172,100 |
2019/05/28 | 3,225 | 3,260 | 3,190 | 3,235 | +5 | +0.2% | 396,500 |
2019/05/27 | 3,215 | 3,230 | 3,190 | 3,230 | +15 | +0.5% | 106,800 |
2019/05/24 | 3,165 | 3,220 | 3,165 | 3,215 | +35 | +1.1% | 137,700 |
2019/05/23 | 3,080 | 3,190 | 3,080 | 3,180 | +100 | +3.2% | 167,600 |
2019/05/22 | 3,115 | 3,125 | 3,075 | 3,080 | -50 | -1.6% | 122,500 |
2019/05/21 | 3,130 | 3,190 | 3,125 | 3,130 | -45 | -1.4% | 145,500 |
2019/05/20 | 3,180 | 3,220 | 3,165 | 3,175 | ±0 | ±0% | 75,600 |
2019/05/17 | 3,145 | 3,185 | 3,120 | 3,175 | +60 | +1.9% | 153,400 |
2019/05/16 | 3,095 | 3,125 | 3,095 | 3,115 | +15 | +0.5% | 139,000 |
2019/05/15 | 3,040 | 3,110 | 3,025 | 3,100 | +65 | +2.1% | 205,700 |
2019/05/14 | 2,980 | 3,035 | 2,925 | 3,035 | +20 | +0.7% | 154,100 |
2019/05/13 | 3,005 | 3,040 | 2,923 | 3,015 | -10 | -0.3% | 247,200 |
2019/05/10 | 3,155 | 3,170 | 3,015 | 3,025 | -315 | -9.4% | 402,300 |
2019/05/09 | 3,355 | 3,375 | 3,315 | 3,340 | -35 | -1% | 189,400 |
2019/05/08 | 3,375 | 3,385 | 3,330 | 3,375 | -60 | -1.7% | 178,000 |
2019/05/07 | 3,400 | 3,440 | 3,370 | 3,435 | +20 | +0.6% | 198,700 |
2019/04/26 | 3,410 | 3,420 | 3,385 | 3,415 | +15 | +0.4% | 125,700 |
2019/04/25 | 3,390 | 3,415 | 3,365 | 3,400 | +15 | +0.4% | 125,100 |
2019/04/24 | 3,390 | 3,410 | 3,375 | 3,385 | +20 | +0.6% | 158,400 |
2019/04/23 | 3,380 | 3,390 | 3,365 | 3,365 | +15 | +0.4% | 133,500 |
2019/04/22 | 3,350 | 3,365 | 3,340 | 3,350 | +40 | +1.2% | 127,500 |
2019/04/19 | 3,345 | 3,360 | 3,295 | 3,310 | -30 | -0.9% | 125,500 |
2019/04/18 | 3,440 | 3,440 | 3,340 | 3,340 | -100 | -2.9% | 243,100 |
2019/04/17 | 3,375 | 3,440 | 3,370 | 3,440 | +100 | +3% | 204,900 |
2019/04/16 | 3,355 | 3,375 | 3,325 | 3,340 | -30 | -0.9% | 118,200 |
2019/04/15 | 3,325 | 3,380 | 3,325 | 3,370 | +65 | +2% | 168,800 |
2019/04/12 | 3,345 | 3,345 | 3,265 | 3,305 | -40 | -1.2% | 168,200 |
2019/04/11 | 3,320 | 3,365 | 3,295 | 3,345 | +40 | +1.2% | 254,300 |
2019/04/10 | 3,280 | 3,315 | 3,255 | 3,305 | -15 | -0.5% | 152,900 |
2019/04/09 | 3,340 | 3,345 | 3,290 | 3,320 | -45 | -1.3% | 138,700 |
2019/04/08 | 3,400 | 3,400 | 3,355 | 3,365 | -25 | -0.7% | 84,300 |
2019/04/05 | 3,370 | 3,405 | 3,370 | 3,390 | -15 | -0.4% | 85,800 |
2019/04/04 | 3,435 | 3,435 | 3,395 | 3,405 | -40 | -1.2% | 87,100 |
2019/04/03 | 3,465 | 3,480 | 3,415 | 3,445 | ±0 | ±0% | 209,800 |
2019/04/02 | 3,445 | 3,465 | 3,415 | 3,445 | +35 | +1% | 200,600 |
2019/04/01 | 3,465 | 3,470 | 3,385 | 3,410 | +45 | +1.3% | 200,300 |
2019/03/29 | 3,330 | 3,370 | 3,320 | 3,365 | +95 | +2.9% | 212,400 |
2019/03/28 | 3,275 | 3,275 | 3,220 | 3,270 | -45 | -1.4% | 154,200 |
2019/03/27 | 3,380 | 3,385 | 3,310 | 3,315 | -35 | -1% | 216,300 |
2019/03/26 | 3,300 | 3,375 | 3,280 | 3,350 | +105 | +3.2% | 322,900 |
2019/03/25 | 3,275 | 3,280 | 3,230 | 3,245 | -70 | -2.1% | 165,200 |
2019/03/22 | 3,375 | 3,375 | 3,290 | 3,315 | -75 | -2.2% | 205,600 |
2019/03/20 | 3,425 | 3,430 | 3,380 | 3,390 | -20 | -0.6% | 114,200 |
2019/03/19 | 3,420 | 3,430 | 3,385 | 3,410 | -30 | -0.9% | 109,600 |
2019/03/18 | 3,440 | 3,445 | 3,410 | 3,440 | -10 | -0.3% | 183,900 |
2019/03/15 | 3,490 | 3,495 | 3,450 | 3,450 | -15 | -0.4% | 143,200 |
2019/03/14 | 3,490 | 3,490 | 3,440 | 3,465 | +5 | +0.1% | 170,300 |
2019/03/13 | 3,395 | 3,465 | 3,395 | 3,460 | +70 | +2.1% | 228,400 |
2019/03/12 | 3,350 | 3,420 | 3,335 | 3,390 | +65 | +2% | 126,100 |
1451~
1500
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 437,300円 | +5.8% | +1.2% | 2.74% | 14.50倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム